Nrx pharmaceuticals to work with cardinal health to ensure efficient distribution of potential therapies

Radnor, pa., aug. 26, 2021 /prnewswire/ -- nrx pharmaceuticals (nrx) (nasdaq: nrxp) announced today it has signed an agreement with cardinal health to provide third party logistics and distribution of zyesami™ upon the potential emergency use authorization (eua) approval by the us food and drug administration (fda).

NRXP Ratings Summary

NRXP Quant Ranking